Die Übersetzung dieser Seite ist experimentell und in Entwicklung. Wir freuen uns über Ihr !
EC Healthcare Management
Management Kriterienprüfungen 1/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Leslie Lu
Geschäftsführender
HK$20.6m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 21.6% |
| Amtszeit als Geschäftsführer | less than a year |
| Eigentum des Geschäftsführers | n/a |
| Durchschnittliche Amtszeit des Managements | 1.9yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 8.3yrs |
Jüngste Management Updates
Recent updates
EC Healthcare (HKG:2138) Surges 25% Yet Its Low P/S Is No Reason For Excitement
May 13
When Should You Buy EC Healthcare (HKG:2138)?
Apr 26Is EC Healthcare (HKG:2138) A Risky Investment?
Feb 07Slammed 26% EC Healthcare (HKG:2138) Screens Well Here But There Might Be A Catch
Dec 24EC Healthcare's (HKG:2138) Dividend Is Being Reduced To HK$0.005
Dec 08Here's What's Concerning About EC Healthcare's (HKG:2138) Returns On Capital
Dec 01At HK$3.13, Is EC Healthcare (HKG:2138) Worth Looking At Closely?
Sep 15EC Healthcare (HKG:2138) Is Paying Out A Dividend Of HK$0.042
Aug 24Is EC Healthcare (HKG:2138) Using Too Much Debt?
Aug 10EC Healthcare (HKG:2138) Has Announced A Dividend Of HK$0.042
Jul 14EC Healthcare (HKG:2138) Will Pay A Dividend Of HK$0.042
Jun 26Is There Now An Opportunity In EC Healthcare (HKG:2138)?
Jun 15Be Wary Of EC Healthcare (HKG:2138) And Its Returns On Capital
May 12Is EC Healthcare (HKG:2138) Potentially Undervalued?
Mar 08EC Healthcare (HKG:2138) Will Want To Turn Around Its Return Trends
Feb 03EC Healthcare (HKG:2138) Is Paying Out Less In Dividends Than Last Year
Dec 20Is Now An Opportune Moment To Examine EC Healthcare (HKG:2138)?
Oct 25EC Healthcare (HKG:2138) Is Reinvesting At Lower Rates Of Return
Sep 20EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042
Sep 01EC Healthcare's (HKG:2138) Shareholders Will Receive A Smaller Dividend Than Last Year
Jul 28EC Healthcare's (HKG:2138) Dividend Will Be Reduced To HK$0.042
Jul 14EC Healthcare (HKG:2138) Is Reducing Its Dividend To HK$0.042
Jun 26When Should You Buy EC Healthcare (HKG:2138)?
May 26EC Healthcare (HKG:2138) Will Be Hoping To Turn Its Returns On Capital Around
Apr 18Is It Too Late To Consider Buying EC Healthcare (HKG:2138)?
Feb 24EC Healthcare (HKG:2138) Could Easily Take On More Debt
Feb 11EC Healthcare (HKG:2138) Has Announced That It Will Be Increasing Its Dividend To HK$0.10
Dec 26EC Healthcare Just Missed EPS By 18%: Here's What Analysts Think Will Happen Next
Dec 02EC Healthcare (HKG:2138) May Have Issues Allocating Its Capital
Nov 25Should You Investigate EC Healthcare (HKG:2138) At HK$11.10?
Nov 03EC Healthcare (HKG:2138) Is Paying Out A Larger Dividend Than Last Year
Aug 24EC Healthcare (HKG:2138) Could Be Struggling To Allocate Capital
Jul 29Analyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Sep 30 2023 | n/a | n/a | -HK$4m |
| Jun 30 2023 | n/a | n/a | HK$33m |
| Mar 31 2023 | HK$21m | HK$4m | HK$70m |
| Dec 31 2022 | n/a | n/a | HK$93m |
| Sep 30 2022 | n/a | n/a | HK$117m |
| Jun 30 2022 | n/a | n/a | HK$157m |
| Mar 31 2022 | HK$13m | HK$2m | HK$198m |
Vergütung im Vergleich zum Markt: LeslieDie Gesamtvergütung ($USD2.64M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt Hong Kong ($USD349.42K).
Entschädigung vs. Einkommen: LeslieDie Bezüge der Mitarbeiter sind gestiegen, während das Unternehmen unrentabel ist.
Geschäftsführer
Leslie Lu (44 yo)
less than a year
Amtszeit
HK$20,645,000
Vergütung
Mr. Lyn Wade Lu, also known as Leslie, served as Co-Chief Executive Officer & Executive Director at EC Healthcare since August 23, 2021 until November 1, 2023. He serves as Chief Executive Officer at EC He...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Founder & Executive Chairman | 8.6yrs | HK$1.12m | 60.93% HK$ 1.1b | |
| Chief Executive Officer | less than a year | HK$20.65m | keine Daten | |
| CFO & Executive Director | 4.9yrs | HK$12.02m | 0.057% HK$ 1.0m | |
| Chief Operating Officer | 3.5yrs | keine Daten | keine Daten | |
| Chief Operating Officer | 1.9yrs | keine Daten | keine Daten | |
| Associate Director of Accounting | no data | keine Daten | keine Daten | |
| Chief Public Affairs Officer & Chief Dental Officer | 1.9yrs | keine Daten | keine Daten | |
| Sales Director | no data | keine Daten | keine Daten | |
| Chief Business Officer | 3.8yrs | keine Daten | keine Daten | |
| Chief Talent Officer | 1.9yrs | keine Daten | keine Daten | |
| Chief Proposition Officer of Healthcare | 1.4yrs | keine Daten | keine Daten | |
| Company Secretary | 6.8yrs | keine Daten | keine Daten |
1.9yrs
Durchschnittliche Betriebszugehörigkeit
45yo
Durchschnittliches Alter
Erfahrenes Management: 2138Das Führungsteam des Unternehmens gilt nicht als erfahren (1.8 Jahre durchschnittliche Betriebszugehörigkeit), was auf ein neues Team schließen lässt.
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| Founder & Executive Chairman | 8.6yrs | HK$1.12m | 60.93% HK$ 1.1b | |
| CFO & Executive Director | 4.4yrs | HK$12.02m | 0.057% HK$ 1.0m | |
| Independent Non-Executive Director | 8.3yrs | HK$240.00k | 0.025% HK$ 453.0k | |
| Independent Non-Executive Director | 8.3yrs | HK$220.00k | keine Daten | |
| Non Executive Director | 8.8yrs | HK$118.00k | 0.24% HK$ 4.3m | |
| Independent Non-Executive Director | 1.8yrs | HK$70.00k | keine Daten |
8.3yrs
Durchschnittliche Betriebszugehörigkeit
44.5yo
Durchschnittliches Alter
Erfahrener Vorstand: 2138Die Vorstandsmitglieder gelten als erfahren (8.3 Jahre durchschnittliche Amtszeit).